Terazosin Capsule
Product Images NDC 68788-4064
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Terazosin (NDC 68788-4064). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image Description (Figure 02)
Image Description (Figure 03)
This is a chart showing the mean change in peak flow rate from baseline in a long-term, open-label, non-placebo controlled study with a total of 494 participants. The study was carried out over a period of 30 months, with measurements taken at various time points. The chart displays the mean change in milliliters per second (mL/sec) over the duration of the study.*
Terazosin Hydrochloride Capsules 2mg (Image006)
This text contains information about Terazosin Hydrochloride Capsules, a medication prescribed to patients for conditions requiring a 2mg dosage. The capsules are generic for Hytrin and should be stored at a temperature of 20°-25°C while being protected from light and moisture. It mentions a warning that federal law prohibits the transfer of this drug to anyone other than the prescribed patient. The capsules are yellow, capsule-shaped, and have "TEZ" printed on them. The manufacturer listed is OrBi Pharmaceuticals Pvt. Ltd, and it includes details such as the package size, expiration date, and lot number.*
Image Description (Structure001)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.